California asks testing labs not to inflate THC levels
California cannabis regulators have issued several warnings asking the testing laboratories authorized by the state to accurately report test results, under penalty of severe sanctions, including the potential revocation of their license.
The laboratory division of the Department of Cannabis Control (DCC) has begun inspections to confirm (or refute) the test results for cannabis flowers and other products that have already been tested, according to an email notification sent Thursday to accredited laboratories and obtained by MJBizDaily.
«Random testing of over-the-counter products will continue to give consumers confidence that the cannabis products they purchase have been tested and that the test results are accurate,» said Nicole Elliott, director of the DCC, to MJBizDaily by email on Friday.
The letter warns testing laboratories that inflating THC levels and falsifying scientific data constitutes a violation of state law.
«Reporting inaccurate results and falsifying data will result in action being taken against your license, up to and including revocation,» the notice warns.
If the results confirmed by the DCC do not match the results of the tests conducted by the laboratories, companies may be required to relabel their products, the DCC said.
«This may also result in the recall and/or embargo of cannabis or cannabis-based products,» according to the warning.
Why inflate THC levels?
The Studies show such as a product's price, THC percentage, and the recommendations of the budtender are the main factors consumers consider when choosing cannabis. However, there has been a disproportionate emphasis on THC percentage, partly due to the misconception that potency is directly linked to product quality, and partly due to a lack of understanding of the important role played by terpenes and other cannabinoids.
This focus on THC content has prompted companies in the cannabis industry (brands, growers, distributors) to game the system, particularly when economic conditions are difficult for legal operators. While consumers remain fixated on THC content, some companies are willing to deceive customers because they can charge them more.
Products from cannabis with high THC content are selling for higher prices, which has encouraged some cannabis companies and testing laboratories willing to commit fraud to manipulate the results. The industry calls this practice «lab shopping.».
Regulations generally require that the THC content listed on the label fall within a certain percentage range relative to the actual test results. In California, this threshold is 10%, which allows some labs to manipulate results or brands to get creative with their claims.
These questionable practices have led to a systemic problem of power inflation, which is detrimental to all parties involved. The lab shopping has often allowed the worst brands and laboratories to achieve better results, while highly effective brands and science-driven laboratories have suffered.
In recent years, state agencies in Arizona, Colorado, Florida, and Nevada have stepped up enforcement against noncompliant testing laboratories, imposing heavy fines and suspending licenses in some cases.
-
Business4 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in Quebec3 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in New Zealand2 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
Cannabis in Morocco4 weeks ago
Morocco: Three Cannabis-Based Medications Approved for the Treatment of Epilepsy
-
Cannabis in France3 weeks ago
Dr. Pascal Douek, a tireless advocate for medical cannabis in France, has died
-
Business4 weeks ago
The Brazilian medical cannabis market continues to grow
-
Cannabis in Spain4 weeks ago
Spain: Medical Cannabis Is Coming to About 50 Hospitals
-
Cannabis in Germany4 weeks ago
Medical Cannabis in Germany: THC Prices Vary by a Factor of 12


You must be logged in to post a comment Login